Monday, January 29, 2024 6:52:38 PM
"The S-1 process for QIND continues and the subsidiary is in the progress of responding to the SEC. The S-1 was filed in order to raise capital for QIND, and should the abovementioned NASDAQ deal be completed, it would supersede the S-1 by providing considerable direct and indirect funding for QIND to deliver its plans. It will also avoid the potential need for QIND to conduct a reverse split which as longstanding Shareholders will know, we as management have always tried to avoid. In further developments and in addition to its normal course of business, QIND is also in discussions with potential acquisition options in the UK and Texas. "
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM